The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis: a decision analysis

World Journal of Pediatrics : WJP
Paula HeikkiläMatti Korppi

Abstract

This study evaluated the cost-effectiveness of hypertonic saline (HS) inhalations for infant bronchiolitis, compared to normal saline inhalations or standard treatment without inhalations as controls. The decision tree in the decision analysis was used to calculate the expected costs. Actual cost data were obtained from our retrospective case-control study on bronchiolitis treatment. The effectiveness of treatment, based on the hospitalization rate of those admitted to the emergency department and the length of stay (LOS) of those who were hospitalized, was collected from previous studies. For the effectiveness estimations, we made a meta-analysis summarizing the results of the meta-analysis of the Cochrane review in 2013 and the results of 10 studies published after it. The mean hospitalization rate was 24.7% in the HS inhalation group and 32.6% in the control group [risk ratio: 0.80, 95% confidence interval (CI) 0.67-0.96] and the mean LOS was 3.736 (HS group) and 4.292 (controls) days (mean difference: - 0.55 days, 95% CI - 0.96 to - 0.15), respectively. The expected costs per patient, when both inpatients and outpatients were included, were €816 ($1111) in the HS inhalation group and €962 ($1310) in the control group. The e...Continue Reading

References

Feb 24, 2006·Health Economics·Mark J SculpherChris McCabe
Jul 25, 2006·Lancet·Rosalind L Smyth, Peter J M Openshaw
Aug 28, 2007·The Journal of Pediatrics·Brian A KuzikSarah Gander
May 16, 2008·The European Respiratory Journal·P M MatricardiS Lau
Aug 14, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Zhengxiu LuoZhou Fu
Dec 17, 2009·Pediatric Pulmonology·Avigdor Mandelberg, Israel Amirav
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·William S Weintraub
Jul 20, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Z LuoX Yang
Oct 8, 2011·Pulmonary Pharmacology & Therapeutics·Ilke Ozahı IpekAbdulkadir Bozaykut
Jan 14, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D HervásJ A Hervás
Jun 16, 2012·International Journal of Immunopathology and Pharmacology·M Miraglia Del GiudiceD Peroni
Jun 5, 2013·Pediatrics·Kohei HasegawaCarlos A Camargo
Aug 1, 2013·The Cochrane Database of Systematic Reviews·Linjie ZhangTerry P Klassen
Dec 18, 2013·Pediatrics·Jonathan D JacobsJay Pershad
Apr 18, 2014·Current Opinion in Pediatrics·Alan R Schroeder, Jonathan M Mansbach
May 28, 2014·JAMA Pediatrics·Susan WuWilbert H Mason
Jun 28, 2014·The European Respiratory Journal·Jasmijn TeunissenBettina F Loza
Sep 16, 2014·The Pediatric Infectious Disease Journal·Tuomas JarttiCarlos A Camargo
Oct 29, 2014·Pediatrics·Shawn L RalstonSinsi Hernandez-Cancio
May 27, 2015·Italian Journal of Pediatrics·Marcello LanariUNKNOWN Study Group of Italian Society of Neonatology on Risk Factors for RSV Hospitalization
Jun 4, 2015·BMJ : British Medical Journal·Valentina RicciUNKNOWN Guideline Development Group and Technical Team

❮ Previous
Next ❯

Citations

Nov 4, 2020·BMC Health Services Research·Jefferson Antonio Buendía, Ranniery Acuña-Cordero

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.